News

Article

Psychedelics Beyond Clinical Settings Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients shared or expressed interest in psychedelics for therapeutic purposes outside of clinical settings?

Yes, patient(s) have shared their interest
No, patient(s) have not talked about it
Related Videos
Related Content
depression
December 18th 2024

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder
December 17th 2024

First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder

Megan McSweeney
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
patients
November 26th 2024

Moving Along

Dinah Miller, MD
ketamine
October 30th 2024

Psychiatrists Utilizing Ketamine-Assisted Psychotherapy

Miriam Schultz, MD
© 2024 MJH Life Sciences

All rights reserved.